Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RA2159 | Tofacitinib | 0.3 | uM | 4 | MCP-1 (MCAF) | 3320.5 | 80 | ||||
| N2586 | IL-17A | 100 | ng/mL | 4 | MCP-1 (MCAF) | 8383.0 | 67 | ||||
| N2586 | EO1428 | 1.0 | uM | IL-17A | 100 | ng/mL | 4 | MCP-1 (MCAF) | 8898.0 | 68 | |
| N2586 | PI103 | 0.1 | uM | IL-17A | 100 | ng/mL | 4 | MCP-1 (MCAF) | 9861.0 | 77 | |
| N2586 | Sigma A6730 | 3.0 | uM | IL-17A | 100 | ng/mL | 4 | MCP-1 (MCAF) | 9157.0 | 77 | |
| N2586 | JNK-IN-8 | 3.0 | uM | IL-17A | 100 | ng/mL | 4 | MCP-1 (MCAF) | 6591.5 | 80 | |
| N2586 | JNK-IN-11 | 0.3 | uM | IL-17A | 100 | ng/mL | 4 | MCP-1 (MCAF) | 2653.0 | 101 | |
| N2586 | Tofacitinib | 0.3 | uM | 4 | MCP-1 (MCAF) | 1490.0 | 53 | ||||
| RA2159 | IL-6 | 100 | ug/mL | 4 | MCP-1 (MCAF) | 2806.0 | 61 | ||||
| RA2159 | EO1428 | 1.0 | uM | IL-6 | 100 | ug/mL | 4 | MCP-1 (MCAF) | 3127.5 | 60 | |
| RA2159 | PI103 | 0.1 | uM | IL-6 | 100 | ug/mL | 4 | MCP-1 (MCAF) | 2409.0 | 53 | |
| RA2159 | Sigma A6730 | 3.0 | uM | IL-6 | 100 | ug/mL | 4 | MCP-1 (MCAF) | 3349.5 | 52 | |
| RA2159 | JNK-IN-8 | 3.0 | uM | IL-6 | 100 | ug/mL | 4 | MCP-1 (MCAF) | 1511.0 | 54 | |
| RA2159 | JNK-IN-11 | 0.3 | uM | IL-6 | 100 | ug/mL | 4 | MCP-1 (MCAF) | 3085.5 | 86 | |
| RA2159 | Ruxolitinib | 0.3 | uM | 4 | MCP-1 (MCAF) | 3352.0 | 25 | ||||
| N2586 | IL-6 | 100 | ug/mL | 4 | MCP-1 (MCAF) | 6701.5 | 44 | ||||
| N2586 | EO1428 | 1.0 | uM | IL-6 | 100 | ug/mL | 4 | MCP-1 (MCAF) | 6777.0 | 61 | |
| N2586 | PI103 | 0.1 | uM | IL-6 | 100 | ug/mL | 4 | MCP-1 (MCAF) | 5577.0 | 73 | |
| N2586 | Sigma A6730 | 3.0 | uM | IL-6 | 100 | ug/mL | 4 | MCP-1 (MCAF) | 7206.0 | 54 | |
| N2586 | JNK-IN-8 | 3.0 | uM | IL-6 | 100 | ug/mL | 4 | MCP-1 (MCAF) | 5453.5 | 56 | |
| N2586 | JNK-IN-11 | 0.3 | uM | IL-6 | 100 | ug/mL | 4 | MCP-1 (MCAF) | 2206.0 | 76 | |
| N2586 | Ruxolitinib | 0.3 | uM | 4 | MCP-1 (MCAF) | 6801.5 | 66 | ||||
| RA2159 | IL-1 alpha | 100 | ng/mL | 4 | MCP-1 (MCAF) | 11132.0 | 41 | ||||
| RA2159 | EO1428 | 1.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | MCP-1 (MCAF) | 11440.0 | 76 | |
| RA2159 | PI103 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 4 | MCP-1 (MCAF) | 12778.0 | 79 |